Literature DB >> 21496689

Azacitidine: a new medication associated with Sweet syndrome.

Suzanne Tintle, Vishal Patel, Andrea Ruskin, Charles Halasz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21496689     DOI： 10.1016/j.jaad.2010.06.032

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN： 0190-9622            Impact factor:   11.527


× No keyword cloud information.
  5 in total

1.  Histiocytoid Variant of Sweet Syndrome Associated with Azacitidine and Recurrence upon Rechallenge.

Authors:  Sarah Bonazza; Bruce Dalton; Jori Hardin; Andrei Metelitsa
Journal:  Can J Hosp Pharm       Date:  2015 Jul-Aug

2.  Use of azacitidine for myelodysplastic syndromes: controversial issues and practical recommendations.

Authors:  Yoo-Jin Kim; Jun Ho Jang; Jae-Yong Kwak; Je-Hwan Lee; Hyeoung-Joon Kim
Journal:  Blood Res       Date:  2013-06-25

Review 3.  Sweet's syndrome associated with clonal hematopoiesis of indeterminate potential responsive to 5-azacitidine.

Authors:  George Yaghmour; Eric Wiedower; Bassam Yaghmour; Sara Nunnery; Eric Duncavage; Mike G Martin
Journal:  Ther Adv Hematol       Date:  2016-11-29

4.  Complete remission of Sweet's syndrome after azacytidine treatment for concomitant myelodysplastic syndrome.

Authors:  Sara Martinelli; Gian Matteo Rigolin; Genesio Leo; Roberta Gafà; Enrico Lista; Francesca Cibien; Olga Sofritti; Giulia Daghia; Francesco Cavazzini; Antonio Cuneo
Journal:  Int J Hematol       Date:  2014-02-20       Impact factor: 2.490

Review 5.  Insights Into the Pathogenesis of Sweet's Syndrome.

Authors:  Michael S Heath; Alex G Ortega-Loayza
Journal:  Front Immunol       Date:  2019-03-12       Impact factor: 7.561
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.